Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
Status:
Not yet recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
The goal of this non-randomized, prospective, open, one-arm clinical study is to learn about
the clinical efficacy of stem cell eye drops in patients with dry eye disease (DED) who
failed to respond to artificial tear sodium hyaluronate eye drops three times a day for two
weeks.
The main question aims to answer are:
- How effective are stem cell eye drops in patients with DED?
- How safe are stem cell eye drops for patients with DED? Participants will be treated
with mesenchymal stem cells (MSCs) eye drops, 5×10^5 /50μl in each eye, twice a day for
two weeks and they will be followed up for three months after treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School